Recent insider trading activity from TAYTON-MARTIN HELEN KATRINA, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | TAYTON-MARTIN HELEN KATRINA | Chief Business & Strgy Officer | A | Option to purchase Ordinary Shares | 2544432 | $0.00 | 2,544,432.0000 | 1,206,440,978 | 9999.99% | 0.21% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | TAYTON-MARTIN HELEN KATRINA | Chief Business & Strgy Officer | A | Option to purchase Ordinary Shares | 565416 | $0.00 | 565,416.0000 | 1,206,440,978 | 9999.99% | 0.05% |